Deucravacitinib
IM011-134
Phase 2 small_molecule terminated
Quick answer
Deucravacitinib for Alopecia Areata is a Phase 2 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Alopecia Areata
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated